BLRX
BioLineRX
BLRX
BLRX
31 hedge funds and large institutions have $436K invested in BioLineRX in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
68% less capital invested
Capital invested by funds: $1.34M → $436K (-$908K)
Holders
31
Holding in Top 10
–
Calls
$16K
Puts
$1K
Top Buyers
| 1 | +$215K | |
| 2 | +$14.7K | |
| 3 | +$12.3K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$7.56K |
| 5 |
Citigroup
New York
|
+$6.66K |
Top Sellers
| 1 | -$465K | |
| 2 | -$128K | |
| 3 | -$84.3K | |
| 4 |
AI
Atria Investments
Charlotte,
North Carolina
|
-$71.8K |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$43K |